You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 5, May 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Randomized Controlled Trial
 •Obsessive-Compulsive Disorder
 •Psychopharmacology
 •Alert me on articles by topic

Treatment of Trichotillomania With Behavioral Therapy or Fluoxetine

A Randomized, Waiting-List Controlled Study

Agnes van Minnen, PhD; Kees A. L. Hoogduin, MD, PhD; Ger P. J. Keijsers, PhD; Inge Hellenbrand, MA; Gert-Jan Hendriks, MD

Arch Gen Psychiatry. 2003;60:517-522.

Background  Both behavioral therapy (BT) and serotonin reuptake inhibitors have been reported effective in the treatment of trichotillomania. This study examines the efficacy of BT and fluoxetine hydrochloride compared with a waiting-list (WL) control group.

Methods  Forty-three patients with trichotillomania entered a 12-week randomized, WL-controlled study of BT and fluoxetine (60 mg/d). Forty patients (14 in the BT group, 11 in the fluoxetine group, and 15 in the WL group) completed the trial. Treatment effects were evaluated using the Massachusetts General Hospital Hairpulling Scale, and severity of hair loss was rated by independent assessors. In addition, we measured general symptoms of psychopathologic abnormalities and depression.

Results  For reducing the symptoms of trichotillomania, BT was superior. Patients in the BT group showed a significantly greater reduction in trichotillomania symptoms, higher effect sizes (Massachusetts General Hospital Hairpulling Scale: BT, 3.80; fluoxetine, 0.42; and WL, 1.09), and more clinically significant changes (BT, 64%; fluoxetine, 9%; and WL, 20%) than patients in the fluoxetine and WL groups. For severity of hair loss, a similar trend was also found in favor of the BT group. No significant differences between groups were established for general psychopathologic and depressive symptoms.

Conclusions  Behavioral therapy is highly effective for reducing symptoms of trichotillomania in the short term, whereas fluoxetine is not.


From the Department of Clinical Psychology, University of Nijmegen (Drs van Minnen, Hoogduin, and Keijsers and Ms Hellenbrand), and GGz Nijmegen (Dr Hendriks), Nijmegen, the Netherlands.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Practice corner: managing trichotillomania--no need to pull your hair out
Papazisis et al.
Evid. Based Med. 2008;13:66-67.
FULL TEXT  

The Milwaukee Inventory for Styles of Trichotillomania-Child Version (MIST-C): Initial Development and Psychometric Properties
Flessner et al.
Behav Modif 2007;31:896-918.
ABSTRACT  

Lifting the Veil on Trichotillomania
Chamberlain et al.
Am. J. Psychiatry 2007;164:568-574.
FULL TEXT  

Untreated Trichotillomania and Trichophagia: Surgical Emergency in a Teenage Girl
Salaam et al.
Psychosomatics 2005;46:362-366.
ABSTRACT | FULL TEXT  

Trichotillomania in Childhood: Case Series and Review
Tay et al.
Pediatrics 2004;113:e494-e498.
ABSTRACT | FULL TEXT  

Behavioral Therapy Is the Best BeT for Trichotillomania
Journal Watch Dermatology 2003;2003:2-2.
FULL TEXT  

Behavioral Therapy Pulls Ahead of an SSRI in Treating Trichotillomania
JWatch Psychiatry 2003;2003:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.